Related Experiment Video
Updated: Feb 23, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy
Nicole Rufo1, Abhishek D Garg1, Patrizia Agostinis1
1Cell Death Research & Therapy (CDRT) Lab, Department of Cellular and Molecular Medicine, KU Leuven (University of Leuven), Leuven, Belgium.
Abstract:
The unfolded protein response (UPR) is a conserved pathway that is stimulated when endoplasmic reticulum (ER) proteostasis is disturbed or lost. Accumulating evidence indicates that chronic activation of the UPR supports the main hallmarks of cancer by favoring cancer cell-autonomous and nonautonomous processes, which ultimately foster the immunosuppressive and protumorigenic microenvironment. However, certain forms of therapy-induced ER stress can elicit immunogenic cancer cell death (ICD), which enables the release of key immunostimulatory or danger signals, eventually driving efficient antitumor immunity. In this review, after a brief discussion of the interplay between ER stress and protumorigenic inflammation, we review the relevance of therapy-mediated ER stress pathways in evoking ICD and how they could be used to optimize current immunotherapy approaches against cancer.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
The Extrinsic Apoptotic Pathway
Tumor Immunotherapy
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

